# Rhinocort Aqua Versus Placebo and Fluticasone Propionate

> **NCT00641680** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 750 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Fluticasone propionate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00641680
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641680, "Rhinocort Aqua Versus Placebo and Fluticasone Propionate". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00641680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*